Wag! Group Co(PET)
0.2426+0.0071+3.01%
Login to post
- CommunityCommunity
- NewsNews
- ProfileProfile
- AnnouncementsAnnouncements
- Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025
GlobeNewswire · 03-18 20:05
- Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin AmericaIlluccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
GlobeNewswire · 03-17
- Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdatePress Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
Dow Jones · 03-13
- Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsVoyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
GlobeNewswire · 03-11
- Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s DiseaseLongeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
GlobeNewswire · 03-11
- Loop Announces Senior Leadership Appointments and ChangesLoop Announces Senior Leadership Appointments and Changes
ACCESS Newswire · 03-07
- Press Release: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development MilestonesPress Release: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
Dow Jones · 03-06
- CIBC Reaffirms Their Buy Rating on Pet Valu Holdings Ltd. (PET)CIBC Reaffirms Their Buy Rating on Pet Valu Holdings Ltd. (PET)
TIPRANKS · 03-05
- Pet Valu Holdings Ltd. (PET) Gets a Buy from BarclaysPet Valu Holdings Ltd. (PET) Gets a Buy from Barclays
TIPRANKS · 03-05
- Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease TreatmentVoyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment
MT Newswires Live · 03-03
- Cassava Sciences Reports 2024 Financial Results and Provides Business UpdateCassava Sciences Reports 2024 Financial Results and Provides Business Update
GlobeNewswire · 03-03
- Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s DiseaseVoyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease
GlobeNewswire · 03-03
- Lantheus Holdings Faces Uncertainty Amid Potential PET Scanner ShortageLantheus Holdings Faces Uncertainty Amid Potential PET Scanner Shortage
TIPRANKS · 02-27
- CIBC Sticks to Its Buy Rating for Pet Valu Holdings Ltd. (PET)CIBC Sticks to Its Buy Rating for Pet Valu Holdings Ltd. (PET)
TIPRANKS · 02-26
- Lantheus Reports Fourth Quarter and Full Year 2024 Financial PerformanceLantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
GlobeNewswire · 02-26
- Trust Stamp announces the allowance by USPTO of Non-Provisional Patent Application 17/725,978 entitled: “Interoperable Biometric Representation” unlocking the potential to break vendor lock-in for biometric servicesTrust Stamp announces the allowance by USPTO of Non-Provisional Patent Application 17/725,978 entitled: “Interoperable Biometric Representation” unlocking the potential to break vendor lock-in for biometric services
GlobeNewswire · 02-25
- Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injectionPatients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
Business Wire · 02-25
- Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million
Stockheads · 02-24
Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million - Eight Specialty PET Resins From Eastman Receive RecyClass ApprovalEight Specialty PET Resins From Eastman Receive RecyClass Approval
ACCESS Newswire · 02-24
- Stifel Nicolaus Remains a Hold on Pet Valu Holdings Ltd. (PET)Stifel Nicolaus Remains a Hold on Pet Valu Holdings Ltd. (PET)
TIPRANKS · 02-24
Loading ...
High
0.2500
Open
0.2500
Volume%
1.03
Low
0.2351
Close
0.2355
T/O Rate
0.34%
抱歉，当前请求异常(-1)
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial